Cilazapril

Known as: 6H-Pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid, 9-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)octahydro-10-oxo-, monohydrate, (1S-(1alpha,9alpha(R*)))-, CILAZAPRIL MONOHYDRATE, Cilazapril Hydrate 
A pyridazine angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, cilazapril is rapidly metabolized in the… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
BACKGROUND AND PURPOSE The effects of angiotensin-converting enzyme inhibitor on long-term atrial electrophysiologic and… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVE The effect of spironolactone, cilazapril and their combination on albuminuria was examined in a randomized prospective… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Hypertension and kidney damage in the double transgenic rat (dTGR) harboring both human renin and human angiotensinogen genes are… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1999
1999
The purpose of this study was to compare the angiotensin II type 1 receptor antagonist candesartan cilexitil (candesartan) and… (More)
  • figure 1
  • table 1
  • table 2
  • figure 3
  • figure 2
Is this relevant?
1996
1996
Contrasting information has been reported concerning the course of renal function in NIDDM with hypertension alone or in… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
BACKGROUND Cilazapril is a novel angiotensin converting enzyme inhibitor with antiproliferative effects in the rat model after… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
1992
1992
A multicenter, randomized double-blind study of 6 months' duration was performed in 540 patients (average age 54 years, 57% male… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1991
1991
To determine the importance of angiotensin converting enzyme (ACE) activity in the development of arterial proliferative lesions… (More)
Is this relevant?
1987
1987
Cilazapril 1.25 and 5.0 mg p.o. q.d. was administered in double-blind fashion to two groups of six normal volunteers on 8… (More)
Is this relevant?
1986
1986
Chronic daily administration of cilazapril (1 X 10 mg/kg/day p.o., from age 4 to 14 weeks) to young spontaneously hypertensive… (More)
Is this relevant?